z-logo
open-access-imgOpen Access
Tolerance of Mice to Lipopolysaccharide is Correlated with Inhibition of Caspase‐3‐mediated Apoptosis in Mouse Liver Cells
Author(s) -
LUAN Jie,
ZHOU Bingrong,
DING Hui,
QI Zhongtian
Publication year - 2007
Publication title -
acta biochimica et biophysica sinica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.771
H-Index - 57
eISSN - 1745-7270
pISSN - 1672-9145
DOI - 10.1111/j.1745-7270.2007.00253.x
Subject(s) - apoptosis , lipopolysaccharide , dna fragmentation , biology , caspase 3 , fragmentation (computing) , immunology , caspase , caspase 8 , microbiology and biotechnology , programmed cell death , biochemistry , ecology
Abstract Bacterial endotoxin lipopolysaccharide (LPS) often results in multiple organ failure. However, pre‐exposure of mice to a sublethal dose of LPS renders the animal tolerant to a lethal dose of LPS. This study was designed to determine whether pre‐exposure of a small dose of LPS was able to suppress apoptosis in mice when challenged with LPS in combination with D ‐galactosamine, and to investigate the expression changes of the apoptosis‐associated molecules. The results showed that a characteristic apoptotic DNA fragmentation existed in mouse livers of the LPS‐naive group, but not in control groups; and the mice of the LPS‐naive group were all dead after 2 d. However, in the LPS‐tolerance groups, both the lethal rate and apoptotic DNA fragmentation were suppressed after the mice were challenged with LPS/ D ‐galactosamine, and the protection against the lethality and apoptotic reaction could be maintained for up to 7 d. In this period, significantly lower levels of caspase‐3 and its mRNA appeared in LPS‐tolerant groups compared to those of the LPS‐naive group ( P <0.05), and the caspase‐3 activities gradually recovered as the observation was prolonged. Our findings suggest that LPS tolerance could suppress apoptosis in mouse liver cells, and the expression and activity of caspase‐3 could be down‐regulated. Edited by Pasquali PAOLO

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here